Ag-4-ATP-MWCNT electrode modified with dsDNA as label-free electrochemical sensor for the detection of daunorubicin anticancer drug

Electrochemistry as a Powerful Tool for Investigations of Antineoplastic Agents: A Comprehensive Review

Cancer is most frequently treated with antineoplastic agents (ANAs) that are hazardous to patients undergoing chemotherapy and the healthcare workers who handle ANAs in the course of their duties. All aspects related to hazardous oncological drugs illustrate that the monitoring of ANAs is essential to minimize the risks associated with these drugs. Among all analytical techniques used to test ANAs, electrochemistry holds an important position. This review, for the first time, comprehensively describes the progress done in electrochemistry of ANAs by means of a variety of bare or modified (bio)sensors over the last four decades (in the period of 1982-2021). Attention is paid not only to the development of electrochemical sensing protocols of ANAs in various biological, environmental, and pharmaceutical matrices but also to achievements of electrochemical techniques in the examination of the interactions of ANAs with deoxyribonucleic acid (DNA), carcinogenic cells, biomimetic membranes, peptides, and enzymes. Other aspects, including the enantiopurity studies, differentiation between single-stranded and double-stranded DNA without using any label or tag, studies on ANAs degradation, and their pharmacokinetics, by means of electrochemical techniques are also commented. Finally, concluding remarks that underline the existence of a significant niche for the basic electrochemical research that should be filled in the future are presented.

Electrochemical Biosensors for Whole Blood Analysis: Recent Progress, Challenges, and Future Perspectives

Whole blood, as one of the most significant biological fluids, provides critical information for health management and disease monitoring. Over the past 10 years, advances in nanotechnology, microfluidics, and biomarker research have spurred the development of powerful miniaturized diagnostic systems for whole blood testing toward the goal of disease monitoring and treatment. Among the techniques employed for whole-blood diagnostics, electrochemical biosensors, as known to be rapid, sensitive, capable of miniaturization, reagentless and washing free, become a class of emerging technology to achieve the target detection specifically and directly in complex media, e.g., whole blood or even in the living body. Here we are aiming to provide a comprehensive review to summarize advances over the past decade in the development of electrochemical sensors for whole blood analysis. Further, we address the remaining challenges and opportunities to integrate electrochemical sensing platforms.

Design and fabrication of new anticancer sensor for monitoring of daunorubicin using 1-methyl-3-octylimidazolinium chloride and tin oxide/nitrogen-doped graphene quantum dot nanocomposite electrochemical sensor

In this study, a novel tin oxide/nitrogen-doped graphene quantum dot nanocomposite (SnO₂-NDGQD) and 1-methyl-3-octylimidazolinium chloride (1M3OICl) ionic liquid amplified carbon paste electrode (CPE) was fabricated as an efficient and fast-response sensor to determine daunorubicin, an anticancer drug. The electrochemical characteristics of daunorubicin at the surface of the 1M3OICl/SnO₂-NDGQD/CPE was explored via various voltammetric methods. The high-resolution transmission electron microscope (HR-TEM) images were recorded to examine the morphological structure of the as-synthesized nanocomposites. The 1M3OICl/SnO₂-NDGQD/CPE offered a wide linear concentration of 0.001-280.0 μM with a low detection limit of 0.40 nM at the optimized experimental conditions using square wave voltammetric (SWV) method. In a nutshell, the developed electrode illustrated outstanding selectivity in the presence of interfering agents and long-term stability. The1M3OICl/SnO₂-NDGQD/CPE was used as new and powerful analytical tool for determination of daunorubicin in real samples with recovery range 98.75%-104.8%.

Electrochemical DNA sensors for drug determination

In this review, recent achievements in the development of the DNA biosensors developed for the drug determination have been presented with particular emphasis to the main principles of their assembling and signal measurement approaches. The design of the DNA sensors is considered with characterization of auxiliary components and their necessity for the biosensor operation. Carbon nanomaterials, metals and their complexes as well as electropolymerized polymers are briefly described in the assembly of DNA sensors. The performance of the DNA sensors is summarized within 2017-2022 for various drugs and factors influencing the sensitivity and selectivity of the response are discussed. Special attention is paid to the mechanism of the signal generation and possible drawbacks in the analysis of real samples.

Biosensors in Drug Discovery and Drug Analysis

Background:

The determination of drugs in pharmaceutical formulations and human biologic fluids is important for pharmaceutical and medical sciences. Successful analysis requires low sensitivity, high selectivity and minimum interference effects. Current analytical methods can detect drugs at very low levels but these methods require long sample preparation steps, extraction prior to analysis, highly trained technical staff and high-cost instruments. Biosensors offer several advantages such as short analysis time, high sensitivity, real-time analysis, low-cost instruments, and short pretreatment steps over traditional techniques. Biosensors allow quantification not only of the active component in pharmaceutical formulations, but also the degradation products and metabolites in biological fluids. The present review gives comprehensive information on the application of biosensors for drug discovery and analysis. Moreover, this review focuses on the fabrication of these biosensors.

Methods:

Biosensors can be classified as the utilized bioreceptor and the signal transduction mechanism. The classification based on signal transductions includes electrochemical optical, thermal or acoustic. Electrochemical and optic transducers are mostly utilized transducers used for drug analysis. There are many biological recognition elements, such as enzymes, antibodies, cells that have been used in fabricating of biosensors. Aptamers and antibodies are the most widely used recognition elements for the screening of the drugs. Electrochemical sensors and biosensors have several advantages such as low detection limits, a wide linear response range, good stability and reproducibility. Optical biosensors have several advantages such as direct, real-time and label-free detection of many biological and chemical substances, high specificity, sensitivity, small size and low cost. Modified electrodes enhance sensitivity of the electrodes to develop a new biosensor with desired features. Chemically modified electrodes have gained attention in drug analysis owing to low background current, wide potential window range, simple surface renewal, low detection limit and low cost. Modified electrodes produced by modifying of a solid surface electrode via different materials (carbonaceous materials, metal nanoparticles, polymer, biomolecules) immobilization. Recent advances in nanotechnology offer opportunities to design and construct biosensors. Unique features of nanomaterials provide many advantages in the fabrication of biosensors. Nanomaterials have controllable chemical structures, large surface to volume ratios, functional groups on their surface. To develop proteininorganic hybrid nanomaterials, four preparation methods have been used. These methods are immobilization, conjugation, crosslinking and self-assembly. In the present manuscript, applications of different biosensors, fabricated by using several materials, for drug analysis are reviewed. The biosensing strategies are investigated and discussed in detail.

Results:

Several analytical techniques such as chromatography, spectroscopy, radiometry, immunoassays and electrochemistry have been used for drug analysis and quantification. Methods based on chromatography require timeconsuming procedure, long sample-preparation steps, expensive instruments and trained staff. Compared to chromatographic methods, immunoassays have simple protocols and lower cost. Electrochemical measurements have many advantages over traditional chemical analyses and give information about drug quantity, metabolic fate of drugs, and pharmacological activity. Moreover, the electroanalytical methods are useful to determine drugs sensitively and selectivity. Additionally, these methods decrease analysis cost and require low-cost instruments and simple sample pretreatment steps.

Conclusion:

In recent years, drug analyses are performed using traditional techniques. These techniques have a good detection limit, but they have some limitations such as long analysis time, expensive device and experienced personnel requirement. Increased demand for practical and low-cost analytical techniques biosensor has gained interest for drug determinations in medical sciences. Biosensors are unique and successful devices when compared to traditional techniques. For drug determination, different electrode modification materials and different biorecognition elements are used for biosensor construction. Several biosensor construction strategies have been developed to enhance the biosensor performance. With the considerable progress in electrode surface modification, promotes the selectivity of the biosensor, decreases the production cost and provides miniaturization. In the next years, advances in technology will provide low cost, sensitive, selective biosensors for drug analysis in drug formulations and biological samples.

A Personal Glucose Meter for Label-Free and Washing-Free Biomolecular Detection

We developed a label-free and washing-free method for biomolecular detection using a personal glucose meter (PGM). ATP was selected as a model target, and cascade enzymatic reactions promoted by hexokinase and pyruvate kinase were adopted to link the amount of ATP to glucose that is detectable by a hand-held PGM. In principle, the presence of target ATP enables hexokinase to catalyze the conversion of glucose to glucose 6-phosphate by providing a phosphate group to glucose, and thus the amount of glucose is decreased in proportion to the amount of ATP. In addition, adenosine 5'-diphosphate (ADP), which is generated after hexokinase-catalyzed enzymatic reaction, is recovered to ATP by a pyruvate kinase enzyme. The regenerated ATP is again supplemented to catalyze multiple rounds of cascade enzymatic reactions, leading to signal amplification. As a result, the change of glucose amount that is inversely proportional to ATP amount is simply measured by a hand-held PGM. By employing this strategy, we successfully determined ATP down to 49 nM with high selectivity even in real samples such as tap water, human serum, and bovine urine. Importantly, the developed system does not require expensive modification and washing steps but is conveniently operated with a commercially available PGM, which would pave the way for the development of a simple and cost-effective sensing platform.